Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins
TP53 gene mutations are present in more than half of all human cancers. The resulting proteins are mostly full-length with a single amino acid change and are abundantly expressed in cancer cells. Some of the mutant p53 proteins gain oncogenic functions (GOF) through which it actively contribute to t...
Saved in:
Main Author: | Giovanni Blandino (auth) |
---|---|
Other Authors: | Ygal Haupt (auth) |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2016
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vasculitis In Practice An Update on Special Situations - Clinical and Therapeutic Considerations
Published: (2018) -
Cell Death Autophagy, Apoptosis and Necrosis
Published: (2015) -
Targeting mutant p53 stabilization for cancer therapy
by: Jiajian Wang, et al.
Published: (2023) -
Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
by: Xiangbing Meng, et al.
Published: (2013) -
Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth
by: Lulu Guan, et al.
Published: (2023)